SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Lock-Up Expiration Hell Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (80)6/8/2001 3:08:17 PM
From: tuck  Read Replies (1) | Respond to of 1005
 
BLUE HP manager back in one piece -- but many pieces with nicks -- from vacation in climbing mecca, Yosemite. Still able to type, so nibbling 500 shares of KOSN at $9.20. Next target, $7.50.

Thanks for y'all's help on INGN's licensing situation. Anybody know who's in the lead -- in terms of filing for marketing approval -- in the area of gene therapy using adenoviral vectors? In other words, what company is the regulatory bellwether for INGN, if the FDA's standards are expected to be stringent?

Cheers, Tuck



To: scaram(o)uche who wrote (80)6/13/2001 5:27:19 PM
From: tuck  Read Replies (1) | Respond to of 1005
 
Speaking of VC bailing, now seems a good time for a VGNX update:

insidertrader.com

Today's action more of the same?

siliconinvestor.com

This puts them back at book, and darn near cash.

biz.yahoo.com

There must be leverage in there somewhere for Rick to play it (not saying he has a position now, mind you; I wouldn't know). BLUE HP will try for 2000 shares at 4 1/4 tomorrow.

Cheers, Tuck


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News